H5N1 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsor:   VaxInnate CorporationCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2012 Category: Research Source Type: clinical trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsor:   VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials